当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Maria Calia Araajo
Cancer nursing has evolved to meet the demands of rising cancer incidence, newer and more complex treatment alternatives, and the emergence of pro parts supporting patients from pre-diagnosis, through treatment, survivorship and end of life care. Nurses are included in direct and in-direct care of individuals at risk of, living with and after cancer in diverse contexts. As a result, nurses are situated to have a critical influence on the processes and results of cancer care, through education, investigate, approach, hone and leadership. However, nursing and cancer care face challenges, arising from workforce deficiencies, under-investment in services and under-representation in decisionmaking. We argue for the continued advancement of cancer nursing with basic center on identifying and tending to imbalances in part acknowledgment and access to pro cancer nursing instruction all through Europe. Partnership, trade of learning, and co-design will be central to advancing education, prove and policy to bolster future development in the cancer nursing workforce and embed cancer nurses in investigate and approach setting at local, national and international levels.